CiteULike is a free online bibliography manager. Register and you can start organising your references online.

Taking TRIPS to India -- Novartis, Patent Law, and Access to Medicines Export

The New England Journal of Medicine, Vol. 356, No. 6. (8 February 2007), pp. 541-541.

Citation Format

[Posts]

View FullText article


BigRedBall's tags for this article

access cancer case court implementation india litigation novartis patents pharmaceuticals reform trips

X Reviews [Write a review of this article]

X Find related articles from these CiteULike users

X Find related articles with these CiteULike tags

X Posting History

X Abstract

In Aug and Sep 2006, patients with cancer, lawyers for patient advocacy groups, and representatives of nongovernmental organizations converged on the offices of Novartis in Mumbai, India, to protest the company's efforts to obtain an Indian patent on Gleevec, the company's brand-name version of imatinib mesylate. The protesters also decried the drug's high price: Novartis sells it in India (where only 5% of people have private health insurance) for $26,000 per year; generic-drug manufacturers offer the drug at less than one tenth that price.


X BibTeX record

X RIS record


Privacy Statement | Terms & Conditions
CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.